The San Francisco Giants enter the offseason facing significant questions about their pitching staff after a disappointing 2026 campaign. While injuries have created uncertainty in the starting rotation, improving the bullpen will also be essential if the organization hopes to rebound next season.

One potential target is left-handed reliever Adrian Morejon, who established himself as an important member of the San Diego Padres' bullpen in 2026.

Morejon could offer the Giants an experienced relief option capable of handling meaningful innings in high-pressure situations. However, his performance this season could also make him an expensive addition to an already demanding offseason shopping list.

Morejon, 27, delivered one of the strongest seasons of his major-league career in 2026. The left-hander recorded a 2.83 ERA across 86 innings while making 76 appearances for San Diego.

His workload marked a career high in appearances, demonstrating how regularly the Padres relied on him throughout the season.

Morejon worked as a setup man for closer Mason Miller, placing him in an important role late in games.

For the Giants, pursuing a pitcher with Morejon's recent track record could represent a significant step toward improving a bullpen that needs additional dependable options.

San Francisco has more than one area to address this winter, meaning its front office must weigh the potential benefits of an established reliever against the financial commitment required to acquire one.

Morejon's age could also make him appealing to teams seeking a pitcher who can contribute beyond a short-term window. At 27, he would offer a younger alternative to some of the veteran relievers expected to draw interest on the open market.

Morejon's performance is likely to attract interest from clubs looking to strengthen their late-inning options. The Giants would therefore need to determine whether pursuing him makes sense within their broader roster-building strategy.

His 2026 campaign followed an All-Star selection in 2025, further establishing his reputation as a productive major league reliever.

However, San Francisco must also consider the uncertainty surrounding its starting rotation. Hayden Birdsong, Carson Whisenhunt, Trevor McDonald, and Blade Tidwell are expected to miss significant time while recovering from Tommy John surgery.

With those absences creating additional demands on the pitching staff, the Giants may need to distribute their resources between the rotation and bullpen rather than concentrate on a single area.

Morejon could address one portion of that problem, but signing him would not eliminate the need to acquire additional starting-pitching depth.

The Giants will also have to determine whether Morejon's projected contract demands align with their offseason budget. His recent production suggests he could command a larger commitment than a typical middle reliever, potentially making him a substantial investment.